Evaluation of Kras mutations and angiogenic biomarkers in patients with advanced non-small cell lung cancer (NSCLC) receiving single-agent sorafenib (S).

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Kelly, RJ; Force, J; Rajan, A; Keen, C; Turkbey, B; Cao, L; Raffeld, M; Steinberg, SM; Wright, JJ; Giaccone, G

Published Date

  • May 20, 2010

Published In

Volume / Issue

  • 28 / 15_suppl

Start / End Page

  • 7626 - 7626

Published By

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2010.28.15_suppl.7626